Hemoglobin and Iron Metabolism Practice Questions

Q: Which food source contains the highest amount of iron?

Meat. **Explanation:** The correct answer is **Meat**. In biochemistry and nutrition, dietary iron is classified into two types: **Heme iron** and **Non-heme iron**. 1. **Why Meat is correct:** Meat (especially organ meats like liver and red meat) contains **Heme iron**. Heme iron is highly bioavailable, with an absorption rate of approximately 15–35%. It is absorbed directly into the enterocytes via heme carrier protein 1 (HCP1), unaffected by most dietary inhibitors. 2. **Why other options are incorrect:** * **Milk:** Milk is notoriously **poor in iron**. It is often cited in exams as a "complete food" except for its lack of Iron and Vitamin C. * **Spinach:** While spinach contains iron, it is **Non-heme iron** (ferric form). Its bioavailability is low (2–10%) because spinach also contains **oxalates**, which bind to iron and inhibit its absorption. * **Jaggery:** Jaggery contains iron (often due to processing in iron vessels), but like spinach, it is non-heme iron and lacks the superior absorption profile of animal-based heme iron. **High-Yield Clinical Pearls for NEET-PG:** * **Absorption Site:** Iron is primarily absorbed in the **duodenum** and upper jejunum. * **Enhancers vs. Inhibitors:** Vitamin C (Ascorbic acid) enhances non-heme iron absorption by reducing it from the Ferric ($Fe^{3+}$) to the Ferrous ($Fe^{2+}$) state. Conversely, **Phytates** (cereals), **Oxalates** (spinach), **Tannins** (tea), and **Calcium** inhibit absorption. * **Transport & Storage:** Iron is transported in the blood by **Transferrin** and stored in cells as **Ferritin** (primary) or Hemosiderin. * **Hepcidin:** The key regulatory hormone produced by the liver that inhibits iron absorption by degrading ferroportin.

Q: What is the rate-limiting enzyme of heme synthesis in erythroid tissue?

ALA synthase II. ### Explanation The rate-limiting step of heme synthesis is the condensation of glycine and succinyl-CoA to form **$\delta$-aminolevulinic acid (ALA)**. This reaction is catalyzed by the enzyme **ALA Synthase (ALAS)**, which exists in two distinct isoforms: 1. **ALA Synthase II (ALAS2):** This isoform is specific to **erythroid tissue** (bone marrow). Its activity is primarily regulated by the availability of **intracellular iron**. Since the question specifies erythroid tissue, ALAS2 is the correct answer. 2. **ALA Synthase I (ALAS1):** This isoform is found in the **liver** and other non-erythroid tissues. It is regulated via feedback inhibition by **hemin** (the end product). #### Analysis of Incorrect Options: * **ALA Synthase I (Option C):** While it is the rate-limiting enzyme for heme synthesis in the **liver**, it is not the primary isoform in erythroid cells. * **PBG Deaminase (Option A):** This enzyme (also known as HMB synthase) catalyzes the third step of heme synthesis. A deficiency here leads to **Acute Intermittent Porphyria (AIP)**, but it is not the rate-limiting step. * **Uroporphyrinogen III Synthase (Option B):** This enzyme catalyzes the fourth step. Its deficiency causes **Congenital Erythropoietic Porphyria (Gunther’s disease)**. #### High-Yield Clinical Pearls for NEET-PG: * **Cofactor:** Both ALAS1 and ALAS2 require **Pyridoxal Phosphate (Vitamin B6)** as a cofactor. Sideroblastic anemia can occur if B6 is deficient or inhibited (e.g., by Isoniazid). * **Location:** The ALAS reaction occurs in the **mitochondria**, whereas the subsequent steps (until Ferrochelatase) occur in the cytosol. * **Genetics:** Mutations in the *ALAS2* gene are the most common cause of **X-linked Sideroblastic Anemia**. * **Regulation:** Unlike ALAS1, ALAS2 is **not** inhibited by hemin; this allows erythroid cells to produce the massive amounts of hemoglobin required for RBC maturation.

Q: In the human body, which of the following trace elements is found in the same metabolic pathway or has a close functional relationship with iron?

Zinc. **Explanation:** The correct answer is **Zinc (B)**. The functional relationship between iron and zinc is primarily observed in the synthesis of heme. In the final step of heme biosynthesis, the enzyme **ferrochelatase** inserts ferrous iron ($Fe^{2+}$) into protoporphyrin IX. When iron is deficient, ferrochelatase utilizes zinc as an alternative substrate, leading to the formation of **Zinc Protoporphyrin (ZPP)**. Measuring ZPP levels is a clinically significant screening tool for iron deficiency anemia and lead poisoning. Furthermore, iron and zinc share common transporters in the duodenum (such as DMT1), leading to competitive inhibition during absorption. **Why other options are incorrect:** * **Calcium:** While calcium can inhibit iron absorption, it does not share a direct metabolic pathway or enzymatic co-factor relationship like zinc does in heme synthesis. * **Copper:** Copper is essential for iron *transport* (via ferroxidases like ceruloplasmin and hephaestin), but it is not substituted for iron in metabolic intermediates like zinc is. * **Selenium:** Selenium is a vital component of glutathione peroxidase and deiodinase enzymes; its metabolic pathways are distinct from the iron-porphyrin pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Zinc Protoporphyrin (ZPP):** An elevated ZPP/Heme ratio is one of the earliest markers of iron-depleted erythropoiesis. * **Acrodermatitis Enteropathica:** An autosomal recessive disorder of zinc absorption characterized by periorificial dermatitis, alopecia, and diarrhea. * **Lead Poisoning:** Lead inhibits ferrochelatase, significantly increasing Zinc Protoporphyrin levels, which serves as a diagnostic marker.

Q: Which hemoglobin appears first in the fetus?

Hb Gowers. **Explanation:** The synthesis of hemoglobin undergoes a sequential transition during embryonic, fetal, and neonatal life, reflecting the changing sites of erythropoiesis. **1. Why Hb Gowers is Correct:** Hemoglobin synthesis begins in the **yolk sac** during the first few weeks of gestation (mesoblastic stage). The very first hemoglobins to appear are the **embryonic hemoglobins**, which include **Hb Gower-1** ($\zeta_2\epsilon_2$), **Hb Gower-2** ($\alpha_2\epsilon_2$), and **Hb Portland** ($\zeta_2\gamma_2$). Among these, Hb Gower-1 is typically the earliest to be detected. By the end of the first trimester (around 10–12 weeks), as erythropoiesis shifts to the liver, these embryonic forms are replaced by fetal hemoglobin (HbF). **2. Why the other options are incorrect:** * **Hb F ($\alpha_2\gamma_2$):** Known as fetal hemoglobin, it is the predominant hemoglobin from the 12th week of gestation until birth. While it is the "major" hemoglobin of the fetus, it is **not the first** to appear. * **Hb A ($\alpha_2\beta_2$):** This is adult hemoglobin. Synthesis begins in small amounts around the 20th week of gestation but only becomes the dominant form approximately 6 months after birth. * **Hb A2 ($\alpha_2\delta_2$):** A minor adult hemoglobin. It appears in very small quantities late in fetal life and normally comprises <3.5% of total hemoglobin in adults. **High-Yield Clinical Pearls for NEET-PG:** * **Globin Chain Switch:** The transition follows the order: $\zeta \rightarrow \alpha$ (alpha-like) and $\epsilon \rightarrow \gamma \rightarrow \beta$ (beta-like). * **Site of Erythropoiesis:** Yolk sac (3–8 weeks) $\rightarrow$ Liver (6–30 weeks) $\rightarrow$ Bone Marrow (from 20 weeks onwards). * **HbF Affinity:** HbF has a higher affinity for oxygen than HbA because it binds **2,3-BPG** less strongly, facilitating oxygen transfer from mother to fetus across the placenta.

Q: All of the following are hepatic porphyrias, EXCEPT?

Protoporphyria. **Explanation:** Porphyrias are metabolic disorders caused by deficiencies in the enzymes of the heme biosynthetic pathway. They are traditionally classified based on the primary site of overproduction and accumulation of porphyrin precursors into **Hepatic** and **Erythropoietic** types. **Why Protoporphyria is the correct answer:** **Protoporphyria** (specifically Erythropoietic Protoporphyria or EPP) is classified as an **Erythropoietic porphyria**. It results from a deficiency of the enzyme **Ferrochelatase**. In this condition, protoporphyrin IX accumulates primarily in the reticulocytes and bone marrow, leading to severe cutaneous photosensitivity. **Analysis of Incorrect Options:** * **Acute Intermittent Porphyria (AIP):** A classic **Hepatic** porphyria caused by Porphobilinogen deaminase deficiency. It presents with neurological symptoms (abdominal pain, psychosis) but no photosensitivity. * **Variegate Porphyria (VP):** A **Hepatic** porphyria caused by Protoporphyrinogen oxidase deficiency. It presents with both neurological symptoms and cutaneous photosensitivity. * **Porphyria Cutanea Tarda (PCT):** The most common **Hepatic** porphyria, caused by Uroporphyrinogen decarboxylase deficiency. It is characterized by chronic skin blistering and is often associated with liver damage or iron overload. **High-Yield Clinical Pearls for NEET-PG:** * **Most common porphyria:** Porphyria Cutanea Tarda (PCT). * **Most common acute porphyria:** Acute Intermittent Porphyria (AIP). * **Enzyme deficient in AIP:** PBG Deaminase (HMB Synthase). * **Photosensitivity:** Absent in AIP (because the block is before the formation of porphyrin rings). * **Urine finding in AIP:** Urine darkens on standing (due to oxidation of PBG to porphobilin).

Q: Which of the following molecules has a strong affinity for hemoglobin and acts in the blood as a "mop-up" molecule to bind free hemoglobin?

Haptoglobin. **Explanation:** **Haptoglobin** is an acute-phase reactant protein synthesized by the liver. Its primary physiological role is to bind free hemoglobin (Hb) released into the plasma during intravascular hemolysis. This binding forms a large **Haptoglobin-Hemoglobin (Hp-Hb) complex**, which is too large to be filtered by the renal glomeruli, thereby preventing iron loss through urine and protecting the kidneys from hemoglobin-induced oxidative damage (tubular necrosis). The complex is rapidly cleared from circulation by the reticuloendothelial system (specifically via CD163 receptors on macrophages). **Analysis of Incorrect Options:** * **Ferritin:** This is the primary **intracellular storage form** of iron, found mainly in the liver and spleen. While small amounts circulate in the blood (reflecting total body iron stores), it does not bind free hemoglobin. * **Transferrin:** This is the primary **transport protein for iron** ($Fe^{3+}$) in the plasma. It delivers iron to bone marrow and other tissues but does not interact with intact hemoglobin molecules. * **Albumin:** While it is a versatile transport protein, it does not bind free hemoglobin. However, it can bind **Heme** (forming methemalbumin) once haptoglobin is saturated. **High-Yield Clinical Pearls for NEET-PG:** * **Hemolysis Marker:** A **decreased serum haptoglobin level** is a highly specific marker for **intravascular hemolysis** (e.g., G6PD deficiency, HUS, or AIHA), as the protein is consumed faster than the liver can synthesize it. * **Hemopexin:** If haptoglobin is depleted, **Hemopexin** acts as a secondary backup to bind free Heme. * **Acute Phase Reactant:** Since haptoglobin levels rise during inflammation, a "normal" level in an inflammatory state might mask underlying hemolysis.

Q: Barbiturates precipitate symptoms of porphyria because:

they induce ALA synthase. ### Explanation **Why Option A is Correct:** The rate-limiting step of heme synthesis is catalyzed by the enzyme **ALA Synthase (ALAS1)**. Barbiturates are potent inducers of the **Cytochrome P450 (CYP450)** system in the liver. Since CYP450 is a hemeprotein, its increased production consumes the intracellular "free heme pool." Heme normally exerts **negative feedback inhibition** on ALA Synthase. When the heme pool is depleted (due to its utilization for CYP450), this feedback inhibition is lifted, leading to the induction of ALA Synthase. In patients with underlying porphyrias (like Acute Intermittent Porphyria), this induction causes a massive overproduction of toxic porphyrin precursors (ALA and PBG), precipitating an acute attack. **Why Other Options are Incorrect:** * **Option B:** Inhibiting ALA synthase would actually decrease the production of porphyrin precursors and is the goal of treatment (e.g., using Hemin), not the cause of an attack. * **Options C & D:** Heme oxygenase is the rate-limiting enzyme in **heme degradation** (converting heme to biliverdin). While its induction might decrease heme levels, the primary mechanism of barbiturate-induced porphyria is specifically linked to the demand for CYP450 and the subsequent induction of ALA Synthase. **NEET-PG High-Yield Pearls:** * **Rate-limiting enzyme:** ALA Synthase (requires **Pyridoxal Phosphate/Vitamin B6** as a cofactor). * **Acute Intermittent Porphyria (AIP):** Most common acute porphyria; characterized by the "5 Ps": **P**ainful abdomen, **P**ort-wine urine, **P**olyneuropathy, **P**sychological disturbances, and **P**recipitated by drugs (Barbiturates, Sulfonamides, Phenytoin). * **Treatment of Acute Attack:** Intravenous **Hemin** or Glucose (both inhibit ALA Synthase). * **Enzyme Deficient in AIP:** Porphobilinogen (PBG) Deaminase.

Q: What is the rate-limiting step in porphyrin synthesis?

ALA synthase. **Explanation:** The synthesis of heme (porphyrin) begins in the mitochondria. The **correct answer is B: ALA synthase (ALAS)**. This enzyme catalyzes the condensation of Succinyl CoA and Glycine to form $\delta$-aminolevulinic acid (ALA). It is the **committed and rate-limiting step** because it is strictly regulated by the end-product, heme, via feedback inhibition and repression of enzyme synthesis. **Analysis of Options:** * **ALA dehydratase (Option A):** Also known as Porphobilinogen synthase, it catalyzes the second step (ALA to Porphobilinogen). While important, it is not the primary rate-limiting enzyme. It is, however, highly sensitive to **lead poisoning**. * **UPG decarboxylase (Option C):** This enzyme converts Uroporphyrinogen III to Coproporphyrinogen III. Deficiency of this enzyme leads to **Porphyria Cutanea Tarda**, the most common porphyria. * **Ferrochelatase (Option D):** This is the final mitochondrial enzyme that inserts ferrous iron ($Fe^{2+}$) into Protoporphyrin IX to form Heme. Like ALA dehydratase, it is inhibited by lead. **High-Yield Clinical Pearls for NEET-PG:** 1. **Cofactor:** ALA synthase requires **Pyridoxal Phosphate (Vitamin B6)**. B6 deficiency can lead to Sideroblastic Anemia. 2. **Isoforms:** There are two forms: **ALAS1** (liver, regulated by heme) and **ALAS2** (erythroid precursors, regulated by iron). 3. **Inducers:** Drugs like Barbiturates and Griseofulvin induce ALAS1 by decreasing the heme pool (via Cytochrome P450 induction), which can precipitate an attack of Acute Intermittent Porphyria (AIP). 4. **Lead Poisoning:** Specifically inhibits ALA dehydratase and Ferrochelatase, leading to elevated ALA levels in urine.

Question 1

Which food source contains the highest amount of iron?

Accepted Answer

Meat

Answer

Milk

Answer

Spinach

Answer

Jaggery

Question 2

What is the rate-limiting enzyme of heme synthesis in erythroid tissue?

Accepted Answer

ALA synthase II

Answer

PBG deaminase

Answer

Uroporphyrinogen III synthase

Answer

ALA synthase I

Question 3

Which property of hemoglobin is affected in sickle cell anemia?

Accepted Answer

Solubility

Answer

Stability

Answer

Function

Answer

Affinity

Question 4

In the human body, which of the following trace elements is found in the same metabolic pathway or has a close functional relationship with iron?

Accepted Answer

Zinc

Answer

Calcium

Answer

Copper

Answer

Selenium

Question 5

Which hemoglobin appears first in the fetus?

Accepted Answer

Hb Gowers

Answer

Hb A

Answer

Hb A2

Answer

Hb F

Question 6

All of the following are hepatic porphyrias, EXCEPT?

Accepted Answer

Protoporphyria

Answer

Variegate porphyria

Answer

Acute intermittent porphyria

Answer

Porphyria Cutanea Tarda

Question 7

Which of the following molecules has a strong affinity for hemoglobin and acts in the blood as a "mop-up" molecule to bind free hemoglobin?

Accepted Answer

Haptoglobin

Answer

Ferritin

Answer

Transferrin

Answer

Albumin

Question 8

Barbiturates precipitate symptoms of porphyria because:

Accepted Answer

they induce ALA synthase

Answer

they inhibit ALA synthase

Answer

they induce heme oxygenase

Answer

they inhibit heme oxygenase

Question 9

What is the rate-limiting step in porphyrin synthesis?

Accepted Answer

ALA synthase

Answer

ALA dehydratase

Answer

UPG decarboxylase

Answer

Ferrochelatase

Question 10

Which of the following statements about Hemoglobin S (HbS) is not true?

Accepted Answer

Binding of HbS to the deoxygenated HbA can extend the polymer and cause sickling of the red blood cells.

Answer

Hemoglobin HbS differs from hemoglobin HbA by the substitution of Val for Glu in position 6 of the beta chain.

Answer

One altered peptide of HbS migrates faster towards the cathode (-) than the corresponding peptide of HbA.

Answer

Lowering the concentration of deoxygenated HbS can prevent sickling.

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?